A new umbrella review brings together more than a decade of evidence on specialist cancer nurse-led care. It finds nurses make their strongest impact in self-management support, symptom management and patient satisfaction, with clear messages for workforce planning.
Gain practical insights into understanding and responding to the evolving needs of people living with CML, from diagnosis through treatment and beyond.
In this webinar recording, Dr Raquel Ruiz Araujo shares practical insights into recognising and managing these reactions, including those caused by EGFR inhibitors.
As of 1 September 2026, nurse practitioners have been able to prescribe PBS-listed medicines for chronic myeloid leukaemia (CML) as a continuation of an existing therapy, where care is shared with a medical practitioner.
